Back to Previous

What Point-of-Care EEG Devices Are Not Telling You

By: | Tags: , , , , , , | July 24th, 2026

By William Dotson, MD | Neurologist, Epileptologist, EEG Service Line Director, TeleSpecialists

Point-of-care EEG devices detect potential seizure activity at the bedside. They do not interpret what that activity means clinically, and the gap between detection and interpretation can determine whether a patient ends up on a ventilator.

I am asked about AI in EEG interpretation often. Device manufacturers are moving fast, and hospital leadership teams are trying to understand what these tools actually deliver and where their limits are. This piece is my direct answer to that question, from someone who reads EEGs every day and evaluates these tools as part of leading TeleSpecialists’ EEG service line.

The short answer: point-of-care EEG devices are valuable. They are not a substitute for a fellowship-trained subspecialist. Understanding the difference, and building your coverage model accordingly, is one of the more consequential decisions a neurology service line can make.

Point-of-Care EEG Was Built to Detect. It Was Not Built to Decide.

Point-of-care EEG technology has changed what is possible at the bedside. A physician, nurse, or trained ancillary staff member can now apply a rapid EEG device to a patient presenting with altered consciousness or concern for seizure activity without waiting for a dedicated EEG technician. For hospitals without around-the-clock technician coverage, that is a meaningful capability.

What the device produces is an algorithmic output. Most point-of-care EEG systems flag waveform patterns consistent with potential seizure activity and prompt the bedside team to take further action. That is what they are engineered to do.

The problem arises when that flagged output is treated as a clinical interpretation rather than a prompt for specialist review.

Algorithmic Output and Clinical Interpretation Are Not the Same Thing

An EEG algorithm identifies waveform patterns that statistically correlate with seizure activity. It does not know the patient’s medication history, prior EEG findings, underlying diagnosis, or the clinical context that allows a trained reader to distinguish artifact from genuine epileptiform discharge.

Fellowship-trained epileptologists evaluate those same waveforms with a layer of subspecialty reasoning the algorithm does not have access to. That is not a criticism of the technology. It is an accurate description of what the technology was and was not designed to do.

In my view, the appropriate role of a point-of-care device is as a prompt. The device flags concern. A subspecialist confirms or rules out the finding and provides direct clinical guidance to the treating team. That confirmation, not the device output, is what tells the team whether to proceed with treatment, hold, or escalate.

Getting that wrong in either direction carries serious consequences. Overtreating based on a device false positive can result in excessive sedation and the need for mechanical ventilation. Undertreating a patient whose seizures were not confirmed by a specialist can allow status epilepticus to continue unmanaged. Neither outcome is acceptable. Neither is inevitable when the human interpretation layer is in place. 

The Highest-Stakes Moment Is Also the Least Covered

Point-of-care EEG matters most in situations involving concern for status epilepticus: a patient who may be seizing continuously, presenting after hours, when a standard EEG setup is not available, and an EEG technician is not on site.

That is precisely the moment when a device read without subspecialist confirmation is most likely to drive a consequential error.

After-hours coverage gaps in EEG interpretation are not rare. They are a standard operational condition for community hospitals, rural facilities, and smaller regional medical centers without 24/7 on-site neurology coverage. The point-of-care device fills the detection gap. Without a specialist available to confirm the finding, the detection gap is simply replaced by an interpretation gap, and the clinical stakes remain unchanged.

At TeleSpecialists, we provide board-certified epileptologist coverage around the clock, every day of the year, with point-of-care EEG interpretation integrated into the service model. When a device flags potential seizure activity, the treating team reaches a fellowship-trained reader who can confirm or rule out the finding and deliver recommendations directly to the care team, documented into the hospital’s existing EMR.

TeleSpecialists has delivered more than 1.5 million patient consultations across more than 400 partner hospitals. Point-of-care EEG interpretation is part of a comprehensive model that covers STAT reads, long-term monitoring, ambulatory studies, and pediatric and neonatal interpretation all by board-certified subspecialists.

My Perspective on AI in EEG: Where the Evidence Is and Where It Is Not

AI-assisted EEG interpretation is among the most actively discussed topics in clinical neurophysiology right now. The American Epilepsy Society, the American Clinical Neurophysiology Society, and the Epilepsy Foundation are all actively addressing where automated interpretation ends and clinical judgment must begin.

The clinical evidence base has not yet supported AI-generated EEG interpretation as a substitute for fellowship-trained subspecialist review in acute clinical settings. What the literature does support is AI as a detection and screening layer that improves access and appropriately flags cases for specialist attention.

I will be direct: AI is influencing EEG practice broadly, and in my observation, the influence is not uniformly positive for patients. The risk is not the technology itself. The risk is how algorithmic output gets positioned and applied at the bedside: whether it is treated as a screening prompt or as a clinical conclusion.

At TeleSpecialists, we do not use AI to replace subspecialist interpretation. Where algorithmic tools contribute to clinical workflow, they function as part of a process that places a board-certified epileptologist as the confirmed reader on every study.

Questions Hospital Leadership Should Be Asking Their EEG Vendor

The market for point-of-care EEG devices and AI-assisted interpretation is moving faster than the evidence base that should govern it. If your hospital is evaluating EEG services, these are the questions I would want answered before making a decision.

Who confirms the algorithmic output when the device flags potential seizure activity? Is that confirmation available at two in the morning on a holiday weekend? What is the credential and training background of the confirming reader? How is the confirmation documented in the EMR, and how quickly does the treating team receive it?

If the answer to any of those questions is unclear or not guaranteed by the vendor, the hospital is carrying clinical and operational risk that the device’s detection capability does not offset.

Frequently Asked Questions

What is point-of-care EEG and how does it differ from a standard EEG study?

Point-of-care EEG uses a simplified electrode setup that can be applied rapidly at the bedside without requiring a dedicated EEG technician. Standard EEG studies involve a full electrode array applied by a trained technician and are ordered for patients who are stable enough to wait. Point-of-care EEG is designed for urgent clinical situations, particularly after-hours presentations with concern for seizure activity or status epilepticus, where speed of setup matters and a standard EEG is not immediately available. The interpretation requirements for both study types are identical: a board-certified epileptologist or neurophysiologist should confirm the findings.

Can AI replace a fellowship-trained epileptologist in reading a point-of-care EEG?

Current AI-assisted EEG systems detect waveform patterns associated with seizure activity. They are not designed to provide a clinical interpretation that accounts for patient history, medication context, prior EEG findings, and the artifact differentiation that fellowship training develops. Professional society guidance from the American Epilepsy Society and the American Clinical Neurophysiology Society supports AI as a detection aid, not a replacement for subspecialist interpretation in acute clinical settings. The two functions serve different roles in the clinical workflow and are not interchangeable.

What happens when a point-of-care EEG result is not confirmed by a subspecialist?

When a point-of-care device flags potential seizure activity and the treating team acts on that output without subspecialist confirmation, clinical decisions are based on algorithmic output alone. Overtreatment based on a device false positive can result in excessive sedation and the need for mechanical ventilation. Undertreatment of genuine seizure activity, including unmanaged status epilepticus, carries risk of lasting neurological injury. Both outcomes are preventable when a board-certified epileptologist is available to confirm or rule out the finding in real time and communicate directly with the treating team.

How does TeleSpecialists integrate with point-of-care EEG devices?

TeleSpecialists provides subspecialist interpretation for point-of-care EEG studies as part of its 24/7 service model. When a device flags potential seizure activity, the treating team contacts TeleSpecialists for subspecialist confirmation. A board-certified epileptologist reviews the study, confirms or rules out epileptiform activity, and provides direct recommendations with findings documented into the hospital’s existing EMR. This integration does not require new hardware or changes to existing communication workflows. Implementation follows established protocols refined across more than 400 partner hospitals.

What credentials should a hospital require from an EEG interpretation service?

Board certification in epilepsy or clinical neurophysiology is the standard credential for EEG interpretation. Fellowship training in epilepsy or clinical neurophysiology ensures the reader has subspecialty depth beyond general neurology training. For pediatric and neonatal EEG studies, fellowship training specific to pediatric neurophysiology is the appropriate credential. TeleSpecialists requires board certification in epilepsy or clinical neurophysiology for all adult EEG readers and pediatric-specific fellowship training for all pediatric and neonatal studies. All readers are subject to monthly peer audit by fellowship-trained colleagues to maintain quality standards across the service line.

Does TeleSpecialists offer point-of-care EEG interpretation as part of a broader EEG service?

Yes. Point-of-care EEG interpretation is available as part of TeleSpecialists’ comprehensive EEG service model, which includes STAT reads, routine interpretations, long-term monitoring, ambulatory studies, and pediatric and neonatal EEG. Hospitals can structure their coverage to include point-of-care interpretation alongside their existing EEG program. TeleSpecialists covers all study types with board-certified subspecialists, documented into the hospital’s native EMR, with around-the-clock availability and direct clinician-to-clinician communication when findings require immediate attention.

The Human Interpretation Layer Is Not Optional

Point-of-care EEG devices have expanded what is possible at the bedside. They have not changed what clinical decision-making requires.

In my practice, and in how we have built the TeleSpecialists EEG service line, the device output is never the conclusion. It is the starting point for a conversation between the bedside team and a fellowship-trained subspecialist who can confirm what the algorithm detected and tell the care team what to do next.

TeleSpecialists has delivered more than 1.5 million patient consultations across more than 400 partner hospitals. If your hospital is evaluating point-of-care EEG devices or reviewing your current EEG interpretation coverage, the question worth asking is not what the device can detect. It is what happens in the minutes after it detects something.

Close the EEG interpretation gap. Connect with the TeleSpecialists team to discuss how subspecialist coverage integrates with your current EEG workflow.

Contact Us

Next Best Content:

Nattasha Acevedo, MD

Dr. Acevedo received her medical degree from the Ponce School of Medicine in Puerto Rico and did her neurology residency at Montefiore Medical Center in New York. She went on to do a clinical neurophysiology fellowship at Emory School of Medicine in Atla nta, Georgia and then joined private practice in Fort Myers, Florida. She currently resides in San Juan, Puerto Rico. She likes running, paddle boarding and spending time with family.
dr-nattasha-acevedo-teleneurology
close-link

Bernadette Borte, MD

Dr. Borte received her medical degree from St. Matthew’s University School of Medicine in Grand Cayman. She completed her neurology residency at the University of Iowa Hospitals and Clinics in Iowa City, Iowa. Her areas of interest include inpatient neurology and acute stroke. When not working, she enjoys spending time outdoors with her family. Dr. Borte joined the TeleSpecialist family in March of 2019.
dr-bernadette-borte-teleneurology
close-link

Mazen Almidani, MD

Dr. Almidani is board certified in pediatrics by the American Board of Pediatrics and board certified in epilepsy, as well as neurology with special  qualification in child neurology by the American Board of Psychiatry and Neurology.  Dr. Almidani is happily married with 4 children. His oldest son has autism and his daughter has complicated seizures; both were a drive for him to become a neurologist. Dr. Almidani enjoys soccer, running and spending time with his family. He is very involved with his sons’ therapy and helping with daily challenges. He is double board certified in Pediatric and Adult Neurology and Epilepsy. He sees children and adults. He also participates in charities for children in Syria who may be underprivileged and/or affected by the war. Dr. Almidani joined TeleSpecialists in August 2020.
close-link

Amanda Cheshire, MD

Dr. Cheshire received her medical degree from the University of Louisville School of Medicine in Louisville, Kentucky. She completed her neurology residency at the University of Cincinnati Medical Center in Cincinnati, Ohio. She did a fellowship in neurophysiology at the University of Michigan Medical School in Ann Arbor, Michigan. Dr. Cheshire is double board certified in neurology and clinical neurophysiology. She enjoys traveling, reading and music. She currently resides in Viera, Florida.  Dr. Cheshire joined TeleSpecialists in June 2019.
dr-amanda-cheshire-teleneurology
close-link

Jessica Floyd, MD

Dr. Floyd completed her neurology residency at Mayo Clinic in Jacksonville, Florida followed by fellowship training in clinical neurophysiology with focus in EEG and epilepsy at the Medical University of South Carolina in Charleston, South Carolina. She has particular interest in hospital neurology and patient education as well as the blossoming specialty of lifestyle medicine. She strives to take advantage of every encounter with patients and medical staff to empower them to do their own research into how daily thoughts, choices, and habits can add up to create greater and longer-lasting brain and neurologic health for ourselves and our loved ones. She lives in Florence, South Carolina with her awesome husband of 13 plus years and three beautiful children. She is an avid yogi, astrologer, and lover of food and all things neurology! Dr. Floyd joined the TeleSpecialist family in July 2017.
dr-jessica-floyd-teleneurology
close-link

Nancy Futrell, MD

Dr. Futrell received her medical degree from the University of Utah in Salt Lake City, Utah. She also did her neurology residency at the University of Utah as well as a research fellowship in cerebral vascular disease at Jackson Memorial Hospital in Miami, Florida. She currently resides in Salt Lake City, Utah. She has authored 2 books and 50 peer reviewed papers. 
dr-nancy-futrell-teleneurology
close-link

Rebecca Jimenez-Sanders, MD

Dr. Jimenez Sanders received her undergraduate degree from Emory University, and her medical degree from the San Juan Bautista School of Medicine in Puerto Rico. She completed her neurology residency at the University of South Florida in Tampa, Florida, where she also did a specialized headache medicine and facial pain fellowship. She currently resides in Tampa, Florida with her husband and her two daughters. She is also fluent in Spanish and Italian languages, and enjoys photography, baking, boating, and biking.
dr-rebecca-jiminez-sanders-teleneurology
close-link

Cory Lamar, MD

Dr. Lamar received his medical degree from Meharry Medical College in Nashville, Tennessee. He completed his internship and residency at Wake Forest Baptist Health in Winston Salem, North Carolina. Following residency, he completed a clinical fellowship in neurophysiology, with a concentration in epilepsy. He currently resides in Florida and enjoys outdoor activities.
close-link

Clifford Meyers, MD

Dr. Meyers received his medical degree from Brown University in Providence, Rhode Island and his MBA from the Simon School of Business at the University of Rochester in Rochester, New York. He completed his neurology residency at the University of Rochester, where he also did a neurophysiology fellowship. Dr. Meyers resides in Webster, New York with his wife and daughter. When not doing teleneurology, he enjoys playing sports with his wife and daughter.
dr-clifford-meyers-teleneurology
close-link

Tao Tong, MD

Dr. Tong received her medical degree from the University of Miami School of Medicine in Miami, Florida. She completed her neurology residency at Jackson Memorial Hospital in Miami, Florida, where she also did a neuromuscular/EMG fellowship.  She currently resides in College Station, Texas. Dr. Tong is married with two boys. She enjoys spending time with her family, traveling and reading.
dr-tao-tong-teleneurology
close-link

Shubhangi Chumble, MD

Dr. Chumble attended BJ Medical School. She is a board certified neurologist with a subspeciality interest in sleep medicine. Dr. Chumble did her residency at Howard University in Washington DC and has practiced neurology since 2001 in private and corporate settings. She lives in Melbourne, Florida and loves the sunshine state. Her hobbies include yoga, meditation, cooking , traveling and meeting new people. She also loves to do stained glass, pottery and painting. She joined TeleSpecialists in June 2019.
close-link